Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with early hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)

Pierre Nahon, Marianne Ziol, Long Pan, Jean-Jacques Portal, Frederic Oberti, Christophe Aube, Jean-Frederic Blanc, Hervé Trillaud, Philippe Merle, Agnès Rode, Eric Assenat, Boris Guiu, Marie Lequoy, François Cornelis, Mohamed Bouattour, Zohra Talib, Annick Tibi, Qinghe Zeng, Yasmine Bouda, Nathalie Ganne-Carrié, Olivier Sutter, Angela Sutton, Erwan Guyot, Nathalie Barget, Jessica Zucman-Rossi, Claudia Campani, Jessica Bamba-Funck, Julien Calderaro, Jean-Charles Nault, Eric Vicaut, Olivier Seror

DOI: 10.1097/hep.0000000000001764

На странице источника доступны аннотация, полный текст или сведения о том, где его прочитать.